XML 32 R23.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stockholders' Equity and Redeemable Convertible Preferred Stock (Tables)
9 Months Ended
Sep. 30, 2018
Stockholders' Equity Note [Abstract]  
Schedule of warrant activity

A summary of warrant activity for the nine months ended September 30, 2018 is presented below:

  

                        Weighted Average  
                                Remaining Contractual  
                Weighted Average               Life  
        Warrants       Exercise Price       Total Intrinsic Value       (in years)  
Outstanding as of December 31, 2017       1,249,754     $ 8.98     $       2.92  
Outstanding as of September 30, 2018       1,249,754     $ 8.98               2.17  
Exercisable as of September 30, 2018       1,249,754     $ 8.98     $       2.17  
Schedule of option activity

A summary of option activity under the Company’s employee stock option plan for the nine months ended September 30, 2018 is presented below:

 

                      Weighted Average  
          Weighted Average           Remaining Contractual  
    Number of Shares     Exercise Price     Total Intrinsic Value     Life (in years)  
Outstanding as of December 31, 2017     325,597     $ 78.20     $ 5,999       3.2  
Employee options granted     200,000       1.39             9.4  
Outstanding as of September 30, 2018     525,597     $ 48.97     $       5.1  
Options vested and expected to vest     525,597     $ 48.97     $       5.1  
Options vested and exercisable     500,597     $ 51.36     $       4.9  

 

A summary of option activity under the Company’s non-employee stock option plan for the nine months ended September 30, 2018 is presented below: 

 

                      Weighted Average  
          Weighted Average           Remaining Contractual  
    Number of Shares     Exercise Price     Total Intrinsic Value     Life (in years)  
Outstanding as of December 31, 2017     2,893     $ 98.07     $       3.4  
Outstanding as of September 30, 2018     2,893     $ 98.07     $       2.7  
Options vested and expected to vest     2,893     $ 98.07     $       2.7  
Options vested and exercisable     2,893     $ 98.07     $       2.7  
Schedule of stock-based compensation

Stock-based compensation for the nine months ended September 30, 2018 and 2017 was comprised of the following ($ in thousands):

 

    For the Three Months Ended September 30,     For the Nine Months Ended September 30,  
    2018     2017     2018     2017  
Employee restricted stock awards   $     $     $ 106     $  
Employee stock option awards     28       2       208       13  
Total compensation expense   $ 28     $ 2     $ 314     $ 13